We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

RBREW:OMXCOPRoyal Unibrew A/S Analysis

Data as of 2026-05-18 - not real-time

DKK 409.60

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Royal Unibrew trades at DKK 409.6, well below its 20‑day (DKK 427.8), 50‑day (DKK 504.3) and 200‑day (DKK 527.7) simple moving averages, signaling a bearish technical backdrop. However, the RSI of 24.6 places the stock in oversold territory and the MACD histogram has turned positive (+3.3), hinting at a possible short‑term bounce toward the DKK 395 support level. Volatility is elevated at 88.7% over the past 30 days, while the beta of 0.13 suggests limited market‑wide risk. Valuation metrics are mixed: a PE of 12.7 looks reasonable, but the discounted cash‑flow fair value of DKK 253.7 is far below the current price, indicating the stock is overvalued.
Fundamentally, the company posted a modest revenue growth of 3.3% and Q1 EBIT surged 25% with margin expansion, supported by a 5% organic volume increase. The dividend yield of 3.9% and a payout ratio near 46% are attractive, yet the balance sheet is strained – a debt‑to‑equity of 92% and cash of only DKK 41 million raise concerns about dividend sustainability. Recent news about the termination of license agreements with PepsiCo in several markets adds a geographic and commercial risk. Overall, the stock shows short‑term technical upside potential but faces medium‑ to long‑term valuation and financial headwinds.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • Oversold RSI (~24) suggesting price floor
  • Bullish MACD histogram indicating momentum shift
  • Proximity to technical support at DKK 395

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Q1 EBIT +25% and margin expansion
  • High leverage (Debt/Equity 92%) limiting upside
  • Current price premium vs DCF fair value

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • Significant overvaluation relative to DCF
  • Debt burden undermining dividend sustainability
  • Loss of PepsiCo licensing could erode market coverage

Key Metrics & Analysis

Financial Health

Revenue Growth3.30%
Profit Margin10.13%
P/E Ratio12.7
ROE23.81%
ROA7.50%
Debt/Equity92.30
P/B Ratio2.9
Op. Cash FlowDKK2.5B
Free Cash FlowDKK1.3B

Technical Analysis

TrendBearish
RSI24.6
SupportDKK 395.00
ResistanceDKK 558.50
MA 20DKK 427.82
MA 50DKK 504.26
MA 200DKK 527.74
MACDBullish
VolumeDecreasing
Fear & Greed Index89.61

Valuation

Fair ValueDKK 253.70
GradeOvervalued
TypeBlend
Dividend Yield3.91%

Risk Assessment

Beta0.13
Volatility88.72%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.